Lactobacillus reuteri NCIMB 30242 and Improved Gastrointestinal Symptoms

• Impact of Oral Administration of Lactobacillus reuteri LMG-P 27481 on Human Gut Microbiota Diversity and Function: A Pilot Study.

  • 2025-11-20
  • Clinical Trial · n = 10
  • Biomedicines 13(11)
  • • Veronica Ojetti
    • Carmine Petruzziello
    • Alessio Migneco
    • Marcello Candelli
    • Angela Saviano

  • PubMed: 41301930
  • DOI: 10.3390/biomedicines13112840

  2 Insights on

  • Improved Gastrointestinal Symptoms

  • Moderate evidence

  This probiotic was safe and was able to improve patients' symptoms.

  Effect

  Beneficial

  Effect size

  Small